中国钩端螺旋体疫苗生产用菌种罗株分子遗传特性分析

目的: 分析研究中国钩端螺旋体疫苗生产用菌种罗株的分子遗传特性,为钩体疫苗生产用菌种分子遗传质量控制方法的研究奠定基础。方法: 通过对罗株16S rRNA基因片段进行PCR扩增、测序,并运用脉冲场凝胶电泳(PFGE)和多位点序列分析(MLST)等方法,对其进行分子分型。结果: 16S rRNA基因序列比对结果显示钩体疫苗生产用菌种罗株基因种为致病性问号型;PFGE分析结果表明该疫苗株全基因组在酶切后共有100~1 000 kb大小不等的片段11个,与我国其他不同血清群代表株酶切片段的数量、大小和分布特征方面明显不同;多位点序列分析得出该罗株序列型为140。结论: 本文对钩体疫苗生产用菌种罗株的分子遗传信息分析结果,可为后续的钩体疫苗生产用菌种分子遗传质量控制方法的研究提供参考。

Objective: To understand the molecular genetic background of strain Luo for production of Leptospira vaccine in China, and provide the foundation for the genetic quality control method of strains for production of Leptospira vaccine in the future. Methods: PCR method was used to amplify 16S rRNA gene and PCR product was sent for sequencing.Pulsed field gel electrophoresis (PFGE) and multiple locus sequence typing (MLST) were used to analyze types of the vaccine strain Luo. Results: The alignment analysis of 16S rRNA gene sequencing revealed that the genetic species of strain Luo for vaccine production was pathogenic Leptospira interrogans.It was observed that the PFGE profile of strain Luo consisted of 11 gene fragments of 100-1 000 kb, which was different from the number, size and distribution characteristics of the representative strains of other different serogroups in China.MLST showed that the ST type of strain Luo was 140. Conclusion: The molecular genetic information of strain Luo for production of Leptospira vaccine obtained in this study provides the reference for the research on genetic quality control methods of strains for Leptospira vaccine production in the future.

[1] YANG HM(杨会棉), JIANG XG(蒋秀高).Molecular typing methods of Leptospira(钩端螺旋体的分子分型方法)[J].Chin J Zoonoses(中国人兽共患病学报), 2011, 27(11):1024
[2] BHARTI AR, NALLU JE, RICALDI JN, et al.Leptospirosis a zoonotic disease of global importance[J].Lancet Infect Dis, 2003, 3(12):757
[3] LEVETT PN.Leptospirosis[J].Chin Microbiol Rev, 2001, 14(5):296
[4] ABELA-RIDDER B, SIKKEMA R, HARTSKEERL RA.Estimating the burden of human leptospirosis[J].Int J Antimicrob Agents, 2010, 36(1):S5
[5] [KG1]HARTSKEERL RA, COLLARES-PEREIA M, ELLIS WA.Emergence, control and re-emerging leptospirosis:dynamics of infection in the changing world[J].Clin Microbiol Infect, 2011, 17(4):494
[6] [KG1]LAURICHESSE H, GOURDON F, SMITS HL, et al.Catalina monovalent inactivated vaccine against Leptospira interrogans serogroup Icterohaemorrhagiae in healthy volunteers[J].Clin Microbiol Infect, 2007, 13(4):395
[7] MOREY RE, GALLOWAY RL, BRAGG SL, et al.Species-specific identification of Leptospiraceae by 16S rRNA gene sequencing[J].J Clin Microbiol, 2006, 44(10):3510
[8] ZHANG Y(张艳), GUO ZQ(郭宗琪), LI XW(李秀文).Establishment of standardized method for pulsed—field gel electrophoresis on Leptospira interrogans and analysis on their patterns(钩端螺旋体脉冲场凝胶电泳标准化技术的建立及谱型特征初步分析)[J].Chin J Epidemiol(中华流行病学杂志), 2007, 28(8):772
[9] NENAD T, ZORAN M, VESNA M, et al.Molecular analysis of Leptospira spp.isolated from humans by restriction fragment length polymorphism, real-time PCR and pulsed-field gel electrophoresis[J].FEMS Microbiol Lett, 2009, 300(1):174
[10] SIRIPHAN B, JANJIRA T, PREMJIT A, et al.A single multilocus sequence typing (MLST) scheme for seven pathogenic Leptospira species[J].PLoS Negl Trop Dis, 2013, 7(1):e1954
[11] BOURHY P, HERRMANN SC, THEODOSE R, et al.Serovar diversity of pathogenic Leptospira circulating in the French West Indies[J].PLoS Negl Trop Dis, 2013, 7(3):e2114
[12] MIRAGLIA F, MATSUO M, MORAIS ZM, et al.Molecular characterization, serotyping, and antibiotic susceptibility profile of Leptospira interrogans serovar Copenhageni isolates from Brazil[J].Diagn Microbiol Infect Dis, 2013, 77(3):195